RE: Good presentation2 Nov 2021 16:44
Looking forward to seeing published Q&A which Investor Meet do well. Yes a bit surprised CFO went as far on future revenues but this underlines growth potential.
Shareholders with 3% + as at 30 September total just under 50% as below. There ought to be more Institutional interest and probably Singer's appointment and more impetus could see movement.
Balderton Capital III, LP (1) 6,813,196 9.9%
Blind Trust (Richard Sharp) 4,447,000 6.4
Credit Suisse 3,937,196 5.7
Chelverton Asset Management 3,889,391 5.6
Dr Adam M Hill (2) 3,537,539 5.1
Genostics Company Ltd 3,335,659 4.8
Mr Timothy Brian Bunting 2,956,717 4.3
UBS Securities 2,843,288 4.1
Hargreaves Lansdown Asset Management 2,401,712 3.5